<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Drug Resist</journal-id><journal-id journal-id-type="iso-abbrev">Infect Drug Resist</journal-id><journal-id journal-id-type="publisher-id">IDR</journal-id><journal-id journal-id-type="pmc">idr</journal-id><journal-title-group><journal-title>Infection and Drug Resistance</journal-title></journal-title-group><issn pub-type="epub">1178-6973</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31118700</article-id><article-id pub-id-type="pmc">6503500</article-id><article-id pub-id-type="publisher-id">193076</article-id><article-id pub-id-type="doi">10.2147/IDR.S193076</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Detection of <italic>Mycoplasma pneumoniae</italic> in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital</article-title><alt-title alt-title-type="running-authors">Merida-Vieyra et al</alt-title><alt-title alt-title-type="running-title">Merida-Vieyra et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Merida-Vieyra</surname><given-names>Jocelin</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref><xref ref-type="aff" rid="AFF0002">2</xref><xref ref-type="author-notes" rid="FT0001"/></contrib><contrib contrib-type="author"><name><surname>Aquino-Andrade</surname><given-names>Alejandra</given-names></name><xref ref-type="aff" rid="AFF0003">3</xref><xref ref-type="author-notes" rid="FT0001"/></contrib><contrib contrib-type="author"><name><surname>Palacios-Reyes</surname><given-names>Deborah</given-names></name><xref ref-type="aff" rid="AFF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Murata</surname><given-names>Chiharu</given-names></name><xref ref-type="aff" rid="AFF0005">5</xref></contrib><contrib contrib-type="author"><name><surname>Ribas-Aparicio</surname><given-names>Rosa Maria</given-names></name><xref ref-type="aff" rid="AFF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>De Colsa Ranero</surname><given-names>Agustin</given-names></name><xref ref-type="corresp" rid="AN0001"/><xref ref-type="aff" rid="AFF0006">6</xref></contrib><aff id="AFF0001"><label>1</label><institution>Molecular Microbiology Laboratory, Instituto Nacional de Pediatria (INP)</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff><aff id="AFF0002"><label>2</label><institution>Biological Production and Control Laboratory, Escuela Nacional de Ciencias Biol&#x000f3;gicas, Instituto Politecnico Nacional</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff><aff id="AFF0003"><label>3</label><institution>Molecular Microbiology Laboratory, INP</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff><aff id="AFF0004"><label>4</label><institution>Department of Pediatric Infectious Diseases, INP</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff><aff id="AFF0005"><label>5</label><institution>Research Methodology, INP</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff><aff id="AFF0006"><label>6</label><institution>Molecular Microbiology Laboratory, Department of Pediatric Infectious Diseases, INP</institution>, <addr-line>Mexico City</addr-line>, <country>Mexico</country></aff></contrib-group><author-notes><corresp id="AN0001">Correspondence: Agustin De Colsa Ranero<addr-line>Insurgentes Sur 3700-C Col., Insurgentes Cuicuilco Delegaci&#x000f3;n Coyoac&#x000e1;n</addr-line>, <addr-line>Mexico City</addr-line>, <addr-line>C.P. 04530</addr-line>, <country>Mexico</country><phone>Tel +1 52 551 084 0900 ext 1859</phone><fax>Fax +1 52 555 606 6856</fax>Email <email xlink:href="agustin.decolsa@infecto.mx">agustin.decolsa@infecto.mx</email></corresp><fn id="FT0001"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>12</volume><fpage>925</fpage><lpage>935</lpage><history><date date-type="received"><day>01</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Merida-Vieyra et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Merida-Vieyra et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><p><bold>Purpose:</bold>
<italic>Mycoplasma pneumoniae</italic> is an important cause of community-acquired pneumonia (CAP). Information on the prevalence of <italic>M. pneumoniae</italic> in pediatric patients with CAP in Mexico is limited. The aim of this study was to detect <italic>M. pneumoniae</italic> in hospitalized pediatric patients with CAP.</p><p><bold>Patients and methods:</bold> We performed a descriptive study in a tertiary-level pediatric reference center, obtaining 154 respiratory samples from patients under 18 years of age and diagnosed with CAP. <italic>M. pneumoniae</italic> was detected by real-time polymerase chain reaction (PCR) targeting the <italic>p1</italic> and <italic>CARDS</italic> genes. Complete blood cell count, measurement of C-reactive protein and detection of IgM and IgG anti-P1 were performed. Clinical, epidemiological and radiological data of the patients were analyzed.</p><p><bold>Results:</bold>
<italic>M. pneumoniae</italic> was detected by real-time PCR in 26.6% of the samples. 39% of the cases occurred during the spring season. A total of 83% of the patients with <italic>M. pneumoniae</italic> had some underlying disease; renal disease, autoimmune disease and primary immunodeficiencies had a significant association with <italic>M. pneumoniae</italic> CAP. Children under 6 years of age represented 53.7% of the cases. Fever and cough were the most frequent symptoms. IgM and IgG were positive in 1.9% and 14% of the patients, respectively. In the chest X-ray, 17.1% of the patients showed multifocal alveolar infiltrates pattern. The complications in this series were 26.8%. The mortality in this study was 4.9%.</p><p><bold>Conclusion:</bold> This is the first report in Mexico about <italic>M. pneumoniae</italic> as a causal agent of CAP in a tertiary care pediatric hospital using real-time PCR and serology. <italic>M. pneumoniae</italic> was responsible for 26.6% of the cases and was frequent in children under 6 years of age. In addition, we described the clinical presentation in patients with underlying diseases.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd><italic>Mycoplasma pneumoniae</italic></kwd><kwd>community-acquired pneumonia</kwd><kwd>pediatrics</kwd><kwd>Mexico</kwd></kwd-group><counts><table-count count="7"/><ref-count count="64"/><page-count count="11"/></counts></article-meta></front><body><sec id="S0001"><title>Introduction</title><p>The most important clinical manifestation of <italic>M<italic>ycoplasma</italic> pneumoniae</italic> in the respiratory tract is community-acquired pneumonia (CAP). School-age children and adolescents are most often affected, but the disease occurs in people of all ages.<xref rid="CIT0001" ref-type="bibr">1</xref><italic>M. pneumoniae</italic> is found worldwide and throughout the year. However, in the US, it has been reported more frequently in the summer or early fall.<xref rid="CIT0002" ref-type="bibr">2</xref> The course of CAP caused by <italic>M. pneumoniae</italic> is generally mild and self-limiting. It is estimated that 3&#x02013;10% of the children with respiratory infection due to <italic>M. pneumoniae</italic> will develop CAP, of whom, up to 5% will require hospitalization,<xref rid="CIT0003" ref-type="bibr">3</xref> and up to 10% of the hospitalized children will be admitted to the intensive care unit (ICU).<xref rid="CIT0004" ref-type="bibr">4</xref></p><p>Culture is still considered the gold standard for the diagnosis of <italic>M. pneumoniae</italic> infection, but slow growth (up to 6 weeks) and low sensitivity (0.04&#x02013;61%) limit its use in the clinical microbiology laboratory.<xref rid="CIT0005" ref-type="bibr">5</xref>&#x02013;<xref rid="CIT0007" ref-type="bibr">7</xref> The disadvantages of serology as a diagnostic method include&#x000a0;variable sensitivity (62.2&#x02013;80%),<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0009" ref-type="bibr">9</xref> the need for paired samples, complicated detection in immunosuppressed patients and ineffective diagnosis in the early phase of infection.<xref rid="CIT0010" ref-type="bibr">10</xref></p><p>Molecular techniques have emerged as an efficient diagnostic tool due to their high sensitivity (85&#x02013;100%) and specificity (98&#x02013;100%),<xref rid="CIT0011" ref-type="bibr">11</xref>&#x02013;<xref rid="CIT0013" ref-type="bibr">13</xref> shorter turnaround time, and the fact that they require only a single sample without the need for viable <italic>M. pneumoniae</italic> organisms.<xref rid="CIT0001" ref-type="bibr">1</xref> Given these advantages, real-time polymerase chain reaction (PCR) has become the main method for <italic>M. pneumoniae</italic> detection.<xref rid="CIT0014" ref-type="bibr">14</xref>&#x02013;<xref rid="CIT0016" ref-type="bibr">16</xref></p><p>The reported frequency of CAP due to <italic>M. pneumoniae</italic> in pediatric patients worldwide varies from 1.5% to 17.6%.<xref rid="CIT0017" ref-type="bibr">17</xref>&#x02013;<xref rid="CIT0019" ref-type="bibr">19</xref> Studies conducted in Latin America report frequencies ranging from 0.74% to 43.8%.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0020" ref-type="bibr">20</xref>&#x02013;<xref rid="CIT0025" ref-type="bibr">25</xref> Most of these reports are from a previously healthy pediatric population.</p><p>Due to the lack of a reference laboratory and personnel trained to perform the culture and the low availability of molecular methods, information on the prevalence of <italic>M. pneumoniae</italic> in pediatric patients with CAP in Mexico is limited.<xref rid="CIT0026" ref-type="bibr">26</xref>&#x02013;<xref rid="CIT0028" ref-type="bibr">28</xref></p><p>The aim of this study was to use real-time PCR and serology to detect <italic>M. pneumoniae</italic> in pediatric patients with CAP who were admitted in a tertiary hospital and to describe the clinical presentation, laboratory data and radiological findings of patients.</p></sec><sec id="S0002"><title>Material and methods</title><sec id="S0002-S2001"><title>Location and study population</title><p>During a period of 16 months (November 2015&#x02013;March 2017), we enrolled 154 pediatric patients (0&#x02013;18 years old) with CAP who were admitted to the Instituto Nacional de Pediatr&#x000ed;a (INP), which is a tertiary-level pediatric reference center with 339 beds and a total of 7,830 discharges per year. The INP has all the pediatric subspecialties; however, the main population consist of immunocompromised patients (cancer, transplant, immunological disorders and primary immunodeficiencies).</p></sec><sec id="S0002-S2002"><title>Clinical data</title><p>Demographic and clinical data as well as biological samples were obtained at the time of admission. The diagnosis of CAP was established based on the presence of the following criteria: Any respiratory signs and symptoms (cough, tachypnea, wheezing) and any sign of respiratory distress with or without the presence of fever presented in outpatient setting and that required hospitalization. None of these patients were admitted in the previous two weeks. Detailed chest examination was performed. Oxygen saturation was measured by pulse oximetry. All the patients have a chest X-ray and any clinical finding were correlated, those radiographs were interpreted by two independent physicians.</p></sec><sec id="S0002-S2003"><title>Standardization of real-time PCR for <italic>M. pneumoniae</italic> detection</title><p>For the standardization of the real-time PCR, primers were designed using the Primer 3 program (v4.0.0), the target sequence for amplification was a segment of the genes <italic>p1</italic> adhesin with 338 bp (F: GTTAACGGCCTCCAGTCAAG, R: GTTTAGCCGCACTGGTTTGT) and Community-Acquired Respiratory Distress Syndrome (<italic>CARDS</italic>) toxin with 452 bp (F: CCGTGTTGATTTGAGAAGCCC, R: CATGACCAGGTTCAACGGGA) from the <italic>M. pneumoniae</italic> ATCC 155310D. The fragments obtained were cloned into the pDrive cloning vector (QIAGEN, Hilden, Germany) according to the instructions of manufacturer. Serial dilutions of the recombinant plasmids (10<xref rid="CIT0007" ref-type="bibr">7</xref>&#x02013;10<sup>0</sup> DNA molecules/&#x003bc;L) were performed to determine the limit of detection of the method. The detection limit was C<sub>T</sub>&#x02264;38.8 for <italic>p1</italic> and at C<sub>T</sub>&#x02264;38.7 for <italic>CARDS</italic> (one copy of genomic DNA/&#x003bc;L).</p></sec><sec id="S0002-S2004"><title>Biological samples</title><p>A nasopharyngeal swab was taken from each patient with a nylon swab (FLOQ Swabs, COPAN Murrieta, CA, USA). DNA extraction was performed using the QIAamp&#x000ae; DNA Mini kit (QIAGEN, Hilden, Germany) according to the instructions of manufacturer. The DNA was eluted in 200 &#x003bc;L of nuclease-free water and stored at &#x02212;20&#x000ba;C until use. Two blood samples were taken: one for the complete blood cell count and another for the measurement of C-reactive protein (CRP) and the detection of IgM and IgG against P1 of <italic>M. pneumoniae</italic>. The interpretation of the hematological&#x000a0;results was performed according to the age of the patients.<xref rid="CIT0029" ref-type="bibr">29</xref> The blood samples were taken in the first week of admission.</p></sec><sec id="S0002-S2005"><title>Detection of <italic>M. pneumoniae</italic> in respiratory samples</title><p>The detection of <italic>M. pneumoniae</italic> in respiratory samples was carried out by real-time PCR amplifying two genomic targets (<italic>p1</italic> and <italic>CARDS</italic>) with primers and probes described previously.<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0030" ref-type="bibr">30</xref> The human <italic>RNaseP</italic> gene was used as an internal amplification control.<xref rid="CIT0031" ref-type="bibr">31</xref> The final volume of the reaction mixture was 25 &#x003bc;L and consisted of 12.5 &#x003bc;L of TaqMan Universal Master Mix II with UNG (Applied Biosystems, Foster City, CA, USA), 0.1 &#x003bc;M each primer for <italic>p1</italic> and <italic>CARDS</italic>, 0.3 &#x003bc;M primers for <italic>RNaseP</italic>, TaqMan probes for <italic>CARDS</italic> (0.2 &#x003bc;M), <italic>p1</italic> (0.25 &#x003bc;M) and <italic>RNaseP</italic> (0.1 &#x003bc;M) and 4 &#x003bc;L DNA. The reactions were performed in triplicate on the ABI-7500 Fast platform (Applied Biosystems). In order to confirm the amplification, in samples with 35&#x0003e;Ct &#x02264;38.8 for the <italic>p1</italic> gene, the products were purified and sequenced using a 3500 XL system (Applied Biosystems). The sequences were analyzed with the blastn algorithm<xref rid="CIT0032" ref-type="bibr">32</xref>,<xref rid="CIT0033" ref-type="bibr">33</xref> to confirm the identity of the fragment.</p></sec><sec id="S0002-S2006"><title>Enzyme immunoassay</title><p>The detection of IgM and IgG antibodies anti-P1 was performed using the Anti-<italic>Mycoplasma pneumoniae</italic> IgM-IgG human ELISA kits (Abcam, Cambridge, UK), following the instructions of manufacturer. The results were expressed in standard units and were interpreted as follows: positive test &#x0003e;11 standard units, indeterminate 9&#x02013;11 standard units and negative test &#x0003c;9 standard units for both immunoglobulins.</p></sec><sec id="S0002-S2007"><title>Statistical analysis</title><p>We compared the overall group of children with CAP with those with <italic>M. pneumoniae</italic> CAP. The JPM 11 software (SAS Institute Inc., Cary, NC, USA) was used. The variables were described as frequencies and percentages. Categorical variables were compared using Pearson&#x02019;s &#x003c7;<xref rid="CIT0002" ref-type="bibr"><italic><sup>2</sup></italic></xref> test. Quantitative variables were analyzed using the Kruskal&#x02013;Wallis test. A value of <italic>P</italic>&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec id="S0003"><title>Results</title><sec id="S0003-S2001"><title>Detection of <italic>M. pneumoniae</italic> by real-time PCR</title><p>Of the respiratory samples of 154 patients in the study, <italic>M. pneumoniae</italic> was detected in 41 (26.6%). The amplification of the 2 genomic targets was positive in 14 respiratory samples (9.1%); the <italic>p1</italic> gene was detected in 26 samples (16.9%), and the <italic>CARDS</italic> gene was only positive in 1 sample (0.9%). The <italic>RNaseP</italic> gene showed values of Ct&#x02264;35 in all the samples. The analysis of the <italic>p1</italic> gene sequences showed 99% identity according to the blastn algorithm.</p></sec><sec id="S0003-S2002"><title>Characteristics of patients with <italic>M. pneumoniae</italic></title><p>Among the patients with <italic>M. pneumoniae</italic>, 51.2% were girls, and 53.7% of cases occurred in patients under 6 years. The proportion of CAP cases occurring in patients over 6 years was higher in <italic>M. pneumoniae</italic> cases (n=19/42) than in the overall study population, and this difference was statistically significant (<italic>P</italic>=0.001). The age groups in which <italic>M. pneumoniae</italic> CAP were more frequent, were those patients under 2 years (31.7%) and those over 12 years (19.5%). The only group in which <italic>M. pneumoniae</italic> CAP was statistically significant were those patients between 10 and 12 years of age (<italic>P</italic>=0.043). Regarding the seasonality, 39% of the cases occurred during spring (<italic>P</italic>&#x0003c;0.001) (<xref rid="T0001" ref-type="table">Table 1</xref>).<table-wrap id="T0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic characteristics in patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Characteristic</th><th rowspan="1" colspan="1">Total, n=154 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Female gender</td><td rowspan="1" colspan="1">68 (44.2)</td><td rowspan="1" colspan="1">21 (51.2)</td><td rowspan="1" colspan="1">0.288</td></tr><tr><td rowspan="1" colspan="1">&#x02265; 6 years of age*</td><td rowspan="1" colspan="1">42 (27.3)</td><td rowspan="1" colspan="1">19 (46.3)</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">&#x0003c;6 years of age</td><td rowspan="1" colspan="1">112 (72.7)</td><td rowspan="1" colspan="1">22 (53.7)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Median age in years (range)</td><td rowspan="1" colspan="1">3.08 (0.04&#x02013;18.3)</td><td rowspan="1" colspan="1">5.41 (0.10&#x02013;17.4)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age group</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003c;2</td><td rowspan="1" colspan="1">68 (44.2)</td><td rowspan="1" colspan="1">13 (31.7)</td><td rowspan="1" colspan="1">0.061</td></tr><tr><td rowspan="1" colspan="1">&#x02003;2, &#x02264;4</td><td rowspan="1" colspan="1">20 (13)</td><td rowspan="1" colspan="1">6 (14.6)</td><td rowspan="1" colspan="1">0.714</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003e;4, &#x02264;6</td><td rowspan="1" colspan="1">24 (15.6)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.088</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003e;6, &#x02264;8</td><td rowspan="1" colspan="1">8 (5.2)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.475</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003e;8, &#x02264;10</td><td rowspan="1" colspan="1">6 (3.9)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.186</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003e;10, &#x02264;12*</td><td rowspan="1" colspan="1">9 (8.5)</td><td rowspan="1" colspan="1">5 (12.2)</td><td rowspan="1" colspan="1">0.043</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x0003e;12</td><td rowspan="1" colspan="1">19 (12.3)</td><td rowspan="1" colspan="1">8 (19.5)</td><td rowspan="1" colspan="1">0.103</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05 statistically significant.</p></fn><fn><p><bold>Abbreviation:</bold> CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p><p>A total of 83% of the patients with <italic>M. pneumoniae</italic> had some underlying diseases, with congenital malformations being the most frequent (29.3%). In comparison to all CAP cases, we found that <italic>M. pneumoniae</italic> CAP was more commonly associated with renal disease, autoimmune disease and primary immunodeficiencies. Only one patient with asthma had <italic>M. pneumoniae</italic> (<xref rid="T0002" ref-type="table">Table 2</xref>).<table-wrap id="T0002" orientation="portrait" position="float"><label>Table 2</label><caption><p>Underlying diseases in patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Diseases</th><th rowspan="1" colspan="1">Total, n=142 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Underlying diseases*</td><td rowspan="1" colspan="1">102 (66.2)</td><td rowspan="1" colspan="1">34 (83)</td><td rowspan="1" colspan="1">0.024</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Renal disease*</td><td rowspan="1" colspan="1">5 (3.2)</td><td rowspan="1" colspan="1">5 (12.2)</td><td rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Neurological disease</td><td rowspan="1" colspan="1">11 (7.1)</td><td rowspan="1" colspan="1">4 (9.8)</td><td rowspan="1" colspan="1">0.448</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Neurodevelopmental disorder</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.758</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Congenital malformation</td><td rowspan="1" colspan="1">40 (26)</td><td rowspan="1" colspan="1">12 (29.3)</td><td rowspan="1" colspan="1">0.574</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Cardiovascular disease</td><td rowspan="1" colspan="1">12 (7.8)</td><td rowspan="1" colspan="1">4 (9.8)</td><td rowspan="1" colspan="1">0.584</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Lung disease other than asthma</td><td rowspan="1" colspan="1">11 (7.1)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.511</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Asthma</td><td rowspan="1" colspan="1">16 (10.4)</td><td rowspan="1" colspan="1">1 (2.4)</td><td rowspan="1" colspan="1">0.051</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Solid tumors</td><td rowspan="1" colspan="1">4 (2.6)</td><td rowspan="1" colspan="1">1 (2.4)</td><td rowspan="1" colspan="1">0.941</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Leukemias and lymphomas</td><td rowspan="1" colspan="1">14 (9.1)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.645</td></tr><tr><td rowspan="1" colspan="1">&#x02003;NNHD</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.639</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Primary immunodeficiency*</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">7 (17.1)</td><td rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Autoimmune disease*</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">5 (12.2)</td><td rowspan="1" colspan="1">0.043</td></tr><tr><td rowspan="1" colspan="1">&#x02003;GERD</td><td rowspan="1" colspan="1">5 (3.2)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.086</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05 statistically significant.</p></fn><fn><p><bold>Abbreviations:</bold> NNHD, non-neoplastic hematological disease; GERD, gastroesophageal reflux disease; CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p><sec id="S0003-S2002-S3001"><title>Clinical presentation</title><p>
In 68.3% of the patients, the course of the disease was acute (less than a week). Fever and cough were the most frequent symptoms. The median duration of fever was three days (range 1&#x02013;10 days), and the median duration of cough was seven days (range 1&#x02013;90 days). Rhinorrhea was observed in 43.9% of the patients and vomiting in 22%. The presence of arthritis/arthralgia differed significantly in the <italic>M. pneumoniae</italic> group (<italic>P</italic>=0.004) (<xref rid="T0003" ref-type="table">Table 3</xref>).<table-wrap id="T0003" orientation="portrait" position="float"><label>Table 3</label><caption><p>Symptoms of patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Symptoms</th><th rowspan="1" colspan="1">Total, n=154 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Acute course (&#x0003c;1 week)</td><td rowspan="1" colspan="1">120 (77.9)</td><td rowspan="1" colspan="1">28 (68.3)</td><td rowspan="1" colspan="1">0.083</td></tr><tr><td rowspan="1" colspan="1">Sub-acute course (&#x0003e;1 week)</td><td rowspan="1" colspan="1">34 (22.1)</td><td rowspan="1" colspan="1">13 (31.7)</td><td rowspan="1" colspan="1">0.083</td></tr><tr><td rowspan="1" colspan="1">Median duration of symptoms in days (range)</td><td rowspan="1" colspan="1">13 (3&#x02013;90)</td><td rowspan="1" colspan="1">13 (3&#x02013;90)</td><td rowspan="1" colspan="1">0.595</td></tr><tr><td rowspan="1" colspan="1">Fever</td><td rowspan="1" colspan="1">135 (87.7)</td><td rowspan="1" colspan="1">33 (80.5)</td><td rowspan="1" colspan="1">0.103</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median days of fever in days (range)</td><td rowspan="1" colspan="1">3 (1&#x02013;19)</td><td rowspan="1" colspan="1">3 (1&#x02013;10)</td><td rowspan="1" colspan="1">0.495</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median temperature in &#x000ba;C (range)</td><td rowspan="1" colspan="1">38.5 (37.3&#x02013;40)</td><td rowspan="1" colspan="1">38.5 (37.9&#x02013;40)</td><td rowspan="1" colspan="1">0.834</td></tr><tr><td rowspan="1" colspan="1">Cough</td><td rowspan="1" colspan="1">145 (94.2)</td><td rowspan="1" colspan="1">39 (95.1)</td><td rowspan="1" colspan="1">0.758</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median days of cough (range)</td><td rowspan="1" colspan="1">6 (1&#x02013;90)</td><td rowspan="1" colspan="1">7 (1&#x02013;90)</td><td rowspan="1" colspan="1">0.283</td></tr><tr><td rowspan="1" colspan="1">Rhinorrhea</td><td rowspan="1" colspan="1">78 (50.6)</td><td rowspan="1" colspan="1">18 (43.9)</td><td rowspan="1" colspan="1">0.313</td></tr><tr><td rowspan="1" colspan="1">Odynophagia</td><td rowspan="1" colspan="1">26 (16.9)</td><td rowspan="1" colspan="1">7 (17.1)</td><td rowspan="1" colspan="1">0.970</td></tr><tr><td rowspan="1" colspan="1">Apnea</td><td rowspan="1" colspan="1">2 (1.3)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.391</td></tr><tr><td rowspan="1" colspan="1">Headache</td><td rowspan="1" colspan="1">7 (4.5)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.905</td></tr><tr><td rowspan="1" colspan="1">Exanthema</td><td rowspan="1" colspan="1">1 (0.6)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.546</td></tr><tr><td rowspan="1" colspan="1">Arthritis/arthralgia*</td><td rowspan="1" colspan="1">3 (1.9)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1">Seizures</td><td rowspan="1" colspan="1">3 (1.9)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.292</td></tr><tr><td rowspan="1" colspan="1">Diarrhea</td><td rowspan="1" colspan="1">15 (9.7)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.235</td></tr><tr><td rowspan="1" colspan="1">Abdominal pain</td><td rowspan="1" colspan="1">12 (7.8)</td><td rowspan="1" colspan="1">4 (9.8)</td><td rowspan="1" colspan="1">0.584</td></tr><tr><td rowspan="1" colspan="1">Vomiting</td><td rowspan="1" colspan="1">36 (23.4)</td><td rowspan="1" colspan="1">9 (22)</td><td rowspan="1" colspan="1">0.801</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05 statistically significant.</p></fn><fn><p><bold>Abbreviation:</bold> CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p><p>
In 95.1% of the patients, some level of oxygen desaturation was observed (SpO<sub>2</sub>&#x0003c;92%), and 82.9% developed respiratory distress. The most frequent signs were crackles (65.9%) and wheezing (43.9%). These signs were not significantly different between both groups. (<xref rid="T0004" ref-type="table">Table 4</xref>)<table-wrap id="T0004" orientation="portrait" position="float"><label>Table 4</label><caption><p>Clinical signs in patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Signs</th><th rowspan="1" colspan="1">Total, n=154 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Tachycardia</td><td rowspan="1" colspan="1">48 (31.2)</td><td rowspan="1" colspan="1">13 (31.7)</td><td rowspan="1" colspan="1">0.931</td></tr><tr><td rowspan="1" colspan="1">Bradycardia</td><td rowspan="1" colspan="1">1 (0.6)</td><td rowspan="1" colspan="1">1 (2.4)</td><td rowspan="1" colspan="1">0.096</td></tr><tr><td rowspan="1" colspan="1">Tachypnea</td><td rowspan="1" colspan="1">118 (76.6)</td><td rowspan="1" colspan="1">31 (75.6)</td><td rowspan="1" colspan="1">0.858</td></tr><tr><td rowspan="1" colspan="1">Oxygen desaturation (SpO<sub>2</sub>&#x0003c;92%)</td><td rowspan="1" colspan="1">148 (96.1)</td><td rowspan="1" colspan="1">39 (95.1)</td><td rowspan="1" colspan="1">0.704</td></tr><tr><td rowspan="1" colspan="1">Respiratory distress</td><td rowspan="1" colspan="1">131 (85.1)</td><td rowspan="1" colspan="1">34 (82.9)</td><td rowspan="1" colspan="1">0.654</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median days of respiratory distress (range)</td><td rowspan="1" colspan="1">2 (1&#x02013;10)</td><td rowspan="1" colspan="1">2 (1&#x02013;10)</td><td rowspan="1" colspan="1">0.598</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Nasal flaring</td><td rowspan="1" colspan="1">61 (39.6)</td><td rowspan="1" colspan="1">14 (34.1)</td><td rowspan="1" colspan="1">0.404</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Intercostal retractions</td><td rowspan="1" colspan="1">127 (82.5)</td><td rowspan="1" colspan="1">32 (78)</td><td rowspan="1" colspan="1">0.385</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Subcostal retractions</td><td rowspan="1" colspan="1">44 (28.6)</td><td rowspan="1" colspan="1">9 (22)</td><td rowspan="1" colspan="1">0.273</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Xiphoid retractions</td><td rowspan="1" colspan="1">72 (46.8)</td><td rowspan="1" colspan="1">17 (41.5)</td><td rowspan="1" colspan="1">0.428</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Thoracoabdominal dissociation</td><td rowspan="1" colspan="1">21 (13.6)</td><td rowspan="1" colspan="1">6 (14.6)</td><td rowspan="1" colspan="1">0.828</td></tr><tr><td rowspan="1" colspan="1">Wheezing</td><td rowspan="1" colspan="1">63 (40.9)</td><td rowspan="1" colspan="1">18 (43.9)</td><td rowspan="1" colspan="1">0.649</td></tr><tr><td rowspan="1" colspan="1">Cyanosis</td><td rowspan="1" colspan="1">30 (19.5)</td><td rowspan="1" colspan="1">6 (14.6)</td><td rowspan="1" colspan="1">0.360</td></tr><tr><td rowspan="1" colspan="1">Crackles</td><td rowspan="1" colspan="1">115 (74.7)</td><td rowspan="1" colspan="1">27 (65.9)</td><td rowspan="1" colspan="1">0.129</td></tr><tr><td rowspan="1" colspan="1">Hypoventilation (breath sounds)</td><td rowspan="1" colspan="1">53 (34.4)</td><td rowspan="1" colspan="1">12 (29.3)</td><td rowspan="1" colspan="1">0.418</td></tr><tr><td rowspan="1" colspan="1">Clinical syndrome of pleural effusion</td><td rowspan="1" colspan="1">8 (5.2)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.915</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Abbreviation:</bold> CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="S0003-S2002-S3002"><title>Laboratory tests</title><p>A complete blood cell count was performed in 142 of 154 pediatric patients with CAP. Of the patients with <italic>M. pneumoniae</italic> (n=37), 18.9% had leukocytosis. The most frequent hematological findings were lymphopenia (56.8%) and monocytosis (59.5%). None of the patients had neutropenia or lymphocytosis. There was thrombocytosis in 8.1% of patients (<italic>P</italic>&#x0003c;0.001) and thrombocytopenia in 21.6%. In three patients, thrombocytopenia was due to their underlying disease (<xref rid="T0005" ref-type="table">Table 5</xref>).<table-wrap id="T0005" orientation="portrait" position="float"><label>Table 5</label><caption><p>Hematological results of patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">Total, n=142 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=37 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Median hemoglobin in g/dL (range)</td><td rowspan="1" colspan="1">12.2 (3.7&#x02013;19.1)</td><td rowspan="1" colspan="1">12.8 (7.3&#x02013;17.1)</td><td rowspan="1" colspan="1">0.205</td></tr><tr><td rowspan="1" colspan="1">Anemia</td><td rowspan="1" colspan="1">31 (21.8)</td><td rowspan="1" colspan="1">5 (13.5)</td><td rowspan="1" colspan="1">0.154</td></tr><tr><td rowspan="1" colspan="1">Leukocytosis</td><td rowspan="1" colspan="1">28 (19.7)</td><td rowspan="1" colspan="1">7 (18.9)</td><td rowspan="1" colspan="1">0.884</td></tr><tr><td rowspan="1" colspan="1">Leukopenia</td><td rowspan="1" colspan="1">26 (18.3)</td><td rowspan="1" colspan="1">7 (18.9)</td><td rowspan="1" colspan="1">0.911</td></tr><tr><td rowspan="1" colspan="1">Neutrophilia</td><td rowspan="1" colspan="1">39 (27.5)</td><td rowspan="1" colspan="1">11 (29.7)</td><td rowspan="1" colspan="1">0.720</td></tr><tr><td rowspan="1" colspan="1">Neutropenia</td><td rowspan="1" colspan="1">5 (3.5)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.017</td></tr><tr><td rowspan="1" colspan="1">Lymphocytosis</td><td rowspan="1" colspan="1">1 (0.7)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.551</td></tr><tr><td rowspan="1" colspan="1">Lymphopenia</td><td rowspan="1" colspan="1">79 (55.6)</td><td rowspan="1" colspan="1">21 (56.8)</td><td rowspan="1" colspan="1">0.873</td></tr><tr><td rowspan="1" colspan="1">Eosinophilia</td><td rowspan="1" colspan="1">9 (6.3)</td><td rowspan="1" colspan="1">2 (5.4)</td><td rowspan="1" colspan="1">0.787</td></tr><tr><td rowspan="1" colspan="1">Monocytosis</td><td rowspan="1" colspan="1">72 (50.7)</td><td rowspan="1" colspan="1">22 (59.5)</td><td rowspan="1" colspan="1">0.215</td></tr><tr><td rowspan="1" colspan="1">Thrombocytosis*</td><td rowspan="1" colspan="1">44 (31)</td><td rowspan="1" colspan="1">3 (8.1)</td><td rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td rowspan="1" colspan="1">Thrombocytopenia</td><td rowspan="1" colspan="1">19 (13.4)</td><td rowspan="1" colspan="1">8 (21.6)</td><td rowspan="1" colspan="1">0.083</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05 statistically significant.</p></fn><fn><p><bold>Abbreviation:</bold> CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p><p>Measurement of CRP was performed in 112 of 154 pediatric patients with CAP. Among the patients with <italic>M. pneumoniae</italic>, 32 samples were obtained. The measured values were in the range of 0.31&#x02013;33.9 mg/L. Elevated values were observed (&#x0003e;0.8 mg/L) in 26 patients (81.3%).</p><p>The detection of anti-P1 antibodies was performed in 107 of 154 pediatric patients with CAP. IgM was detected in 2.8% (n=3) and IgG in 19.6% (n=21) of samples.</p><p>Of the patients with <italic>M. pneumoniae</italic> detected by real-time PCR (n=34), IgM was positive in two samples (1.9%; range 15.4&#x02013;19.5 standard units; <italic>P</italic>=0.188) and IgG in 15 (14%; range 11.2&#x02013;28.3 standard units; <italic>P</italic>&#x0003c;0.001). Of the patients negative for <italic>M. pneumoniae</italic> by real-time PCR, IgM was positive in one sample and IgG was positive in six.</p></sec><sec id="S0003-S2002-S3003"><title>Radiological findings</title><p>With respect to chest X-ray, an interstitial pattern was the most frequent finding (78%), followed by a bronchopneumonia pattern (29.3%). Multifocal alveolar pattern was statistically significant in the <italic>M. pneumoniae</italic> group (17.1%; <italic>P</italic>=0.004) (<xref rid="T0006" ref-type="table">Table 6</xref>).<table-wrap id="T0006" orientation="portrait" position="float"><label>Table 6</label><caption><p>Radiological findings of patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Pattern</th><th rowspan="1" colspan="1">Total, n=154 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Single pattern</bold></td><td rowspan="1" colspan="1">82 (53.2)</td><td rowspan="1" colspan="1">22 (53.7)</td><td rowspan="1" colspan="1">0.951</td></tr><tr><td rowspan="1" colspan="1"><bold>Mixed pattern</bold></td><td rowspan="1" colspan="1">72 (46.8)</td><td rowspan="1" colspan="1">19 (46.3)</td><td rowspan="1" colspan="1">0.951</td></tr><tr><td rowspan="1" colspan="1">Interstitial</td><td rowspan="1" colspan="1">112 (72.7)</td><td rowspan="1" colspan="1">32 (78)</td><td rowspan="1" colspan="1">0.372</td></tr><tr><td rowspan="1" colspan="1">Consolidation</td><td rowspan="1" colspan="1">20 (13)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.207</td></tr><tr><td rowspan="1" colspan="1">Bronchopneumonia</td><td rowspan="1" colspan="1">52 (33.8)</td><td rowspan="1" colspan="1">12 (29.3)</td><td rowspan="1" colspan="1">0.477</td></tr><tr><td rowspan="1" colspan="1">Multifocal*</td><td rowspan="1" colspan="1">11 (7.1)</td><td rowspan="1" colspan="1">7 (17.1)</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1">Atelectasis</td><td rowspan="1" colspan="1">8 (5.2)</td><td rowspan="1" colspan="1">2 (4.9)</td><td rowspan="1" colspan="1">0.915</td></tr><tr><td rowspan="1" colspan="1">Effusion</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.639</td></tr><tr><td rowspan="1" colspan="1">Overdistention</td><td rowspan="1" colspan="1">22 (14.3)</td><td rowspan="1" colspan="1">4 (9.8)</td><td rowspan="1" colspan="1">0.333</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *<italic>P</italic>&#x0003c;0.05 statistically significant.</p></fn><fn><p><bold>Abbreviation:</bold> CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p><p>Approximately 53.7% of the patients had a single radiological pattern, whereas the remainder had mixed radiological patterns. The interstitial-bronchopneumonia combination and the interstitial-overdistension combination were the most frequent (21.1% each) (<xref rid="T0006" ref-type="table">Table 6</xref>).</p></sec><sec id="S0003-S2002-S3004"><title>Complications</title><p>In total, 26.8% of the patients in the group of <italic>M. pneumoniae</italic> had complications, required mechanical ventilation and were admitted to the ICU (<xref rid="T0007" ref-type="table">Table 7</xref>), and 4.9% of the patients died. However, none of these complications were statistically significant.<table-wrap id="T0007" orientation="portrait" position="float"><label>Table 7</label><caption><p>Complications in patients with CAP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Type of complications</th><th rowspan="1" colspan="1">Total, n=154 (%)</th><th rowspan="1" colspan="1"><italic>M. pneumoniae</italic>, n=41 (%)</th><th rowspan="1" colspan="1"><italic>P-</italic>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Complications</td><td rowspan="1" colspan="1">47 (30.5)</td><td rowspan="1" colspan="1">11 (26.8)</td><td rowspan="1" colspan="1">0.483</td></tr><tr><td rowspan="1" colspan="1">Pleural effusion</td><td rowspan="1" colspan="1">9 (5.8)</td><td rowspan="1" colspan="1">3 (7.3)</td><td rowspan="1" colspan="1">0.639</td></tr><tr><td rowspan="1" colspan="1">Pericarditis</td><td rowspan="1" colspan="1">1 (0.6)</td><td rowspan="1" colspan="1">1 (2.4)</td><td rowspan="1" colspan="1">0.096</td></tr><tr><td rowspan="1" colspan="1">Admission to PICU</td><td rowspan="1" colspan="1">40 (26)</td><td rowspan="1" colspan="1">11 (26.8)</td><td rowspan="1" colspan="1">0.884</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median duration of PICU stay in days (range)</td><td rowspan="1" colspan="1">9.5 (3&#x02013;60)</td><td rowspan="1" colspan="1">9 (3&#x02013;60)</td><td rowspan="1" colspan="1">0.867</td></tr><tr><td rowspan="1" colspan="1">Mechanical ventilation</td><td rowspan="1" colspan="1">51 (33.1)</td><td rowspan="1" colspan="1">11 (26.8)</td><td rowspan="1" colspan="1">0.318</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Median days of mechanical ventilation (range)</td><td rowspan="1" colspan="1">9 (3&#x02013;32)</td><td rowspan="1" colspan="1">10 (3&#x02013;25)</td><td rowspan="1" colspan="1">0.582</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Abbreviations:</bold> PICU, pediatric intensive care unit; CAP, community-acquired pneumonia.</p></fn></table-wrap-foot></table-wrap>
</p></sec></sec></sec><sec id="S0004"><title>Discussion</title><p>This study reports the frequency of <italic>M. pneumoniae</italic> in pediatric patients diagnosed with CAP in Mexico. <italic>M. pneumoniae</italic> was identified in 26.6% of the patients, which is very similar to several reports in Asian countries.<xref rid="CIT0034" ref-type="bibr">34</xref>&#x02013;<xref rid="CIT0036" ref-type="bibr">36</xref> However, other studies report lower frequencies; for instance, a multicenter study conducted by the <italic>Centers for Disease Control and Prevention</italic> in three US hospitals found <italic>M. pneumoniae</italic> in 8% of the patients.<xref rid="CIT0017" ref-type="bibr">17</xref> Other authors report lower frequencies ranging from 0.74% (Ecuador) to 6% (Austria).<xref rid="CIT0025" ref-type="bibr">25</xref>,<xref rid="CIT0037" ref-type="bibr">37</xref>&#x02013;<xref rid="CIT0040" ref-type="bibr">40</xref></p><p>We measured the analytical sensibility of the real-time PCR method with Ct&#x02264;38.8 for <italic>p1</italic> gene and Ct&#x02264;38.7 for <italic>CARDS</italic> gene. In 26 respiratory samples, the <italic>p1</italic> gene was positive and <italic>CARDS</italic> gene was not detected. <italic>p1</italic> gene is the most used target in other reports; however, we decided to use both genes in order to improve <italic>M. pneumoniae</italic> detection. Two single nucleotide polymorphisms have been described in <italic>CARDS</italic> gene,<xref rid="CIT0041" ref-type="bibr"><sup>41</sup></xref> one of them is located in the segment where probe is aligned. This could be the reason why <italic>CARDS</italic> gene was not detected.</p><p><italic>M. pneumoniae</italic> infection occurs throughout the year, but there may be seasonal variation. In this study, the highest number of cases of CAP due to <italic>M. pneumoniae</italic> was detected in spring (39%) (<italic>P</italic>&#x0003c;0.001), similar to one study in Poland (32.3%).<xref rid="CIT0042" ref-type="bibr">42</xref> In Serbia and Korea, a higher frequency was found in autumn (33.3% and 48.4%, respectively).<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0043" ref-type="bibr">43</xref> The first of two independent studies conducted in China detected the highest number of cases in summer and autumn,<xref rid="CIT0044" ref-type="bibr">44</xref> whereas the second study showed a peak during the autumn and winter.<xref rid="CIT0045" ref-type="bibr">45</xref> These results indicate that the seasonal behavior of <italic>M. pneumoniae</italic> may be affected by the geographic region.</p><p>In this study, no statistical significance by gender was observed. Among patients with <italic>M. pneumoniae</italic>, 51.2% were female. Similar frequencies have been reported in other studies<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0046" ref-type="bibr">46</xref></p><p>Of the children who had <italic>M. pneumoniae</italic> (n=41/154), 53.7% were under 6 years and 46.3% were over 6 years (<italic>P</italic>&#x0003c;0.001). Previous studies from Korea have reported that 70.9% of the infections occurred in children between 1 and 6 years.<xref rid="CIT0043" ref-type="bibr">43</xref> In China, a frequency of 80% was reported in children under 7 years,<xref rid="CIT0044" ref-type="bibr">44</xref> while in Taiwan, <italic>M. pneumoniae</italic> was found in 48% of the children under 5 years.<xref rid="CIT0034" ref-type="bibr">34</xref> In contrast, a study conducted in the US reported that 73.3% of the pediatric patients with CAP due to <italic>M. pneumoniae</italic> were over 5 years.<xref rid="CIT0004" ref-type="bibr">4</xref> Children of school age (over 6 years) may be more susceptible to infection with <italic>M. pneumoniae</italic>, as school attendance favors overcrowding and increases the risk of infection.</p><p>In total, 83% of the patients with <italic>M. pneumoniae</italic> had an underlying disease (<italic>P</italic>=0.024). Cardiac and respiratory malformations have been reported as risk factors for the development of CAP due to <italic>M. pneumoniae</italic>.<xref rid="CIT0035" ref-type="bibr">35</xref> In Taiwanese children (n=492) with <italic>M. pneumoniae</italic>, 3.1% had an underlying disease (neurological disease, cardiac disease or asthma).<xref rid="CIT0034" ref-type="bibr">34</xref> Because the INP is a reference hospital, this study offers information about CAP due to <italic>M. pneumoniae</italic> in a pediatric population group with underlying diseases. Most of the reports focus on the description of the clinical and epidemiological characteristics of CAP due to <italic>M. pneumoniae</italic> in previously healthy pediatric population.<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0043" ref-type="bibr">43</xref></p><p>Of the underlying diseases observed in our patient population, renal diseases, primary immunodeficiencies and autoimmune disease showed a statistically significant association with <italic>M. pneumoniae</italic> (<italic>P&#x0003c;</italic>0.001). Among the seven patients with immunodeficiency and <italic>M. pneumoniae</italic>, there were three patients with AIDS, two cases of hypogammaglobulinemia, one case of agammaglobulinemia and one case of hyper-IgE syndrome. In a study in India that included 90 patients with AIDS, <italic>M. pneumoniae</italic> was detected in 32.3% of this population.<xref rid="CIT0047" ref-type="bibr">47</xref> A case of a patient with pneumonia due to <italic>M. pneumoniae</italic> who had hyper-IgM syndrome has been previously reported.<xref rid="CIT0048" ref-type="bibr">48</xref> Our results indicate that in patients with immunodeficiencies who present with CAP, <italic>M. pneumoniae</italic> should be suspected as the etiologic agent.</p><p>Associations between <italic>M. pneumoniae</italic> and asthma have been described in previous studies. In France, <italic>M. pneumoniae</italic> was detected in 13.6% of the children with chronic asthma.<xref rid="CIT0049" ref-type="bibr">49</xref> In Paraguay, in a study of 56 pediatric patients with asthma, <italic>M. pneumoniae</italic> was detected more frequently in children with severe asthma (22.2%) compared to children with stable asthma (6.9%).<xref rid="CIT0050" ref-type="bibr">50</xref> In this study, of the 16 patients with asthma and CAP, <italic>M. pneumoniae</italic> was detected only in one patient (6.3%). Regarding clinical presentation, fever (80.5%; <italic>P</italic>=0.103) and cough (95.1%; <italic>P</italic>=0.758) were the most frequent symptoms, as reported by other authors.<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0024" ref-type="bibr">24</xref>,<xref rid="CIT0034" ref-type="bibr">34</xref>,<xref rid="CIT0046" ref-type="bibr">46</xref> The association of <italic>M. pneumoniae</italic> with arthritis/arthralgias was statistically significant (<italic>P</italic>=0.004), which has not been previously reported. Other studies have suggested an association of headache and wheezing with infection by <italic>M. pneumoniae</italic> (<italic>P</italic>&#x0003c;0.05).<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0051" ref-type="bibr">51</xref> In this study, 43.9% of the patients had wheezing and 4.9% had headaches, but there was no statistically significant association; however, some of the children were not old enough to report this symptom. Other symptoms such as vomiting (22%), abdominal pain (9.8%) and diarrhea (4.9%) were found in patients with <italic>M. pneumoniae</italic>. Similarly, in Taiwanese children with <italic>M. pneumoniae</italic>, 20.5% had vomiting, 15.7% had abdominal pain and 11.8% had diarrhea.<xref rid="CIT0034" ref-type="bibr">34</xref> With respect to the clinical signs, 82.9% of the patients presented some degree of respiratory distress, a higher prevalence than reported in a study from Colombia (73%),<xref rid="CIT0052" ref-type="bibr"><sup>52</sup></xref> Poland (48%)<xref rid="CIT0042" ref-type="bibr">42</xref> and Serbia (8.3%).<xref rid="CIT0009" ref-type="bibr">9</xref> In these studies, children were previously healthy, which could explain this difference. We found that 65.9% of the patients had crackles, greater than reported in Korean (51.5%) and Chinese patients (38.6%).<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0053" ref-type="bibr">53</xref> None of the clinical signs evaluated in this study showed statistically significant associations with <italic>M. pneumoniae</italic>. Other studies found no relationship between clinical presentation and CAP due to <italic>M. pneumoniae</italic>.<xref rid="CIT0042" ref-type="bibr">42</xref>,<xref rid="CIT0054" ref-type="bibr">54</xref> These findings show that the diagnosis of CAP due to <italic>M. pneumoniae</italic> can rarely be established based on the clinical presentation alone.</p><p>Regarding the laboratory data, only 18.9% of the patients had leukocytosis, a prevalence lower than that reported in a study in China (24.3%).<xref rid="CIT0055" ref-type="bibr">55</xref> Other study carried out in the same country reported that 58.8% of the patients had leukocytosis.<xref rid="CIT0036" ref-type="bibr">36</xref> In Korean patients, there was no difference in the count of leukocytes, but the authors noted that lymphopenia could occur with <italic>M. pneumoniae</italic> infection.<xref rid="CIT0056" ref-type="bibr">56</xref> In our study, 56.8% of the patients (<italic>P</italic>=0.873) had lymphopenia. An inverse association was observed between thrombocytosis and the presence of <italic>M. pneumoniae</italic> (8.1%; <italic>P</italic>&#x0003c;0.001). The frequency of thrombocytosis has been reported to range from 8% to 58%.<xref rid="CIT0056" ref-type="bibr">56</xref>,<xref rid="CIT0057" ref-type="bibr">57</xref> In a study conducted in Serbia, there was no difference in the leukocyte and platelet counts with <italic>M. pneumoniae</italic> infection.<xref rid="CIT0009" ref-type="bibr">9</xref> Pneumonia caused by <italic>Streptococcus pneumoniae</italic> could increase the number of leukocytes and neutrophils and in viral CAP lymphocytosis is more common. In this study, there was not a distinct hematological finding associated with <italic>M. pneumoniae</italic>.</p><p>Approximately 81.3% of the patients with <italic>M. pneumoniae</italic> had high levels of CRP (&#x0003e;0.82 mg/L; <italic>P</italic>=0.223). One study found that in Chinese children, 62.9% of the patients had a CRP level &#x0003e;8 mg/L,<xref rid="CIT0055" ref-type="bibr">55</xref> but other study reported only 26.6% with high values.<xref rid="CIT0036" ref-type="bibr">36</xref> In Serbian children, there was no difference in CRP levels with <italic>M. pneumoniae</italic>.<xref rid="CIT0009" ref-type="bibr">9</xref> This suggests that CRP is not a good marker for the presence of <italic>M. pneumoniae.</italic></p><p>Of the 41 patients who tested positive for <italic>M. pneumoniae</italic> by real-time PCR, IgM and IgG were positive in 1.9% and 14%, respectively. Some studies that used real-time PCR as the gold standard found that the ranges of sensitivity and specificity of serology were 62.2&#x02013;80% and 85.5&#x02013;98.6%, respectively.<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0009" ref-type="bibr">9</xref> In Chinese children, <italic>M. pneumoniae</italic> was identified by real-time PCR in more patients (15.6%) compared to serology (IgM) (12.1%).<xref rid="CIT0058" ref-type="bibr">58</xref> . In our study, the samples that had positive real-time PCR and negative serology, the presence of immunodeficiencies in some patients could have affected the production of antibodies. In other patients who did not have an underlying disease, the difference in days between the onset of symptoms and blood sampling might not have allowed the development of an immune response. The diagnosis of <italic>M. pneumoniae</italic> must be accompanied by an analysis of the clinical history, the underlying disease previous antimicrobial treatments and epidemiological factors, as the choice of the best technique for detection of <italic>M. pneumoniae</italic> will depend on this assessment and its interpretation.</p><p>Regarding the radiological findings, we found that the interstitial pattern was the most frequent in both groups (78%; <italic>P</italic>=0.372), as has been reported in Poland (85.8%).<xref rid="CIT0042" ref-type="bibr">42</xref> In Japan, the interstitial pattern was documented only in 28.2% of the patients, whereas the consolidation pattern was the most common radiological finding (87.3%), followed by bronchopneumonia (60.6%).<xref rid="CIT0059" ref-type="bibr">59</xref> In this study, bronchopneumonia was observed in 29.3% of the patients and consolidation only in 7.3%, other studies have reported consolidation as the most common radiological finding.<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0060" ref-type="bibr">60</xref> The multifocal pattern was statistically significantly associated with <italic>M. pneumoniae</italic> (17.1%; <italic>P</italic>=0.004). This radiological pattern was reported also in 38.6% of the Chinese children.<xref rid="CIT0055" ref-type="bibr">55</xref><xref rid="CIT0061" ref-type="bibr"/> In contrast, in Serbian children, no association was found between radiological findings and infection with <italic>M. pneumoniae</italic>.<xref rid="CIT0009" ref-type="bibr">9</xref> These data indicate that the presence of <italic>M. pneumoniae</italic> has not a characteristic radiological pattern.</p><p>Patients with <italic>M. pneumoniae</italic> pneumonia presented complications in 26.8%. The most frequent complications in our patients were admission to the pediatric ICU (PICU; <italic>P</italic>=0.884) and mechanical ventilation (<italic>P</italic>=0.318). In Taiwan, 26% of the patients had complications, the frequency of admission to the PICU was 22.1% and the use of mechanical ventilation occurred in 5.5% of the patients.<xref rid="CIT0034" ref-type="bibr">34</xref> Other studies report lower frequencies: in the US, it was reported that 10.8% of the patients were admitted to the PICU and 1.7% required mechanical ventilation.<xref rid="CIT0004" ref-type="bibr">4</xref> In Israel, admission to the PICU was reported in 4.6% (n=8) of the patients, of whom two died.<xref rid="CIT0061" ref-type="bibr">61</xref> In this study, one of the child who died required admission to PICU and mechanical ventilation.</p><p>The mortality in this study was 4.9% (n=2). One of the patients had an underlying disease (AIDS, congenital heart disease and gastroesophageal reflux) and the second child was previously healthy. Infection with <italic>M. pneumoniae</italic> could contribute to both deaths. In Taiwan, the death of six children with <italic>M. pneumoniae</italic> CAP was reported; of these, half had an underlying disease.<xref rid="CIT0062" ref-type="bibr">62</xref> In Texas, an outbreak of this pathogen was reported in five previously healthy siblings, two of whom died of respiratory complications.<xref rid="CIT0063" ref-type="bibr">63</xref> It is important to mention that up to 25% of the people infected with <italic>M. pneumoniae</italic> may have extrapulmonary complications,<xref rid="CIT0064" ref-type="bibr">64</xref> which can lead to increased mortality.</p></sec><sec id="S0005"><title>Conclusions</title><p>This study demonstrated the involvement of <italic>M. pneumoniae</italic> as a cause of CAP in Mexican pediatric patients. The frequency was 26.6%. Classically, <italic>M. pneumoniae</italic> pneumonia is referred more frequently in patients over 5 years, we found that 53.7% were under 6 years. The course of CAP due to <italic>M. pneumoniae</italic> usually is self-limited; however, we found that 26.8% of the patients have come complications and 4.6% died. Most of the reported studies of <italic>M. pneumoniae</italic> CAP have been reported in previously healthy children; in this study, 83% of the patients had underlying diseases, so this report offers important data regarding <italic>M. pneumoniae</italic> pneumonia in this group of patients. The use of molecular techniques was more efficient in the detection of <italic>M. pneumoniae</italic> than serological tests. Because the treatment of <italic>M. pneumoniae</italic> in children is different from other CAP-causing microorganisms, timely detection of this pathogen could reduce the development of complications, the presence of extrapulmonary manifestations and patient mortality.</p></sec></body><back><ack><title>Acknowledgments</title><p>We appreciate the technical support of MsC Aaron Rodriguez Caballero. This project was kindly funded by Instituto Cientifico Pfizer (Fondo de Investigacion Epidemiologica 2014) and the 2015 Federal Budget Research Funds (Fondos de Presupuesto Federal para Investigacion) of the INP.</p></ack><sec id="S0006"><title>Abbreviations list</title><p>CAP, community-acquired pneumonia; RT-PCR, real-time polymerase chain reaction; CRP, C-reactive protein; INP, Instituto Nacional de Pediatria; CARDS, Community-Acquired Respiratory Distress Syndrome; SNPs, single nucleotide polymorphisms; PICU, pediatric intensive care unit; AIDS, acquired immune deficiency syndrome.</p></sec><sec id="S0007"><title>Ethics</title><p>This study was approved by the Research and Ethics Committees of the INP (Institutional Review Board: 00008064, reference number 14/058), following the guidelines of the Declaration of Helsinki. Written informed consent was obtained from a parent or guardian of each child enrolled in the study.</p></sec><sec id="S0008"><title>Author contributions</title><p>Jocelin Merida Vieyra performed the acquisition, analysis and interpretation of data, and drafted the initial manuscript. Alejandra Aquino Andrade was responsible for the conception and design, the acquisition, analysis and interpretation of data, acquisition of funding, and drafting the initial manuscript. Deborah Palacios Reyes contributed to obtaining informed consent, the acquisition, analysis and interpretation of data, and review and editing of the manuscript. Chiharu Murata performed the analysis and interpretation of data&#x000a0;and review and editing of the manuscript. Rosa Maria Ribas-Aparicio analyzed the data and reviewed and edited the manuscript. Agustin De Colsa Ranero was responsible for the conception and design, the analysis and interpretation of data, acquisition of funding, and review and editing of the manuscript. All authors read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.</p></sec><sec id="S0009" sec-type="COI-statement"><title>Disclosure</title><p>The authors report no conflicts of interest in this work. </p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Waites</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Balish</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>TP</given-names></string-name>. <article-title><italic>Mycoplasma pneumoniae</italic> from the respiratory tract and beyond</article-title>. <source><italic toggle="yes">Clin Microbiol Rev</italic></source>. <year>2017</year>;<volume>30</volume>(<issue>3</issue>):<fpage>747</fpage>&#x02013;<lpage>809</lpage>.<pub-id pub-id-type="pmid">28539503</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="book"><string-name><surname>Waites</surname>
<given-names>KB</given-names></string-name>. <chapter-title>What&#x02019;s new in diagnostic testing and treatment approaches for <italic>Mycoplasma pneumoniae</italic> infections in children?</chapter-title> In: <string-name><surname>Curtis</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Finn</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pollard</surname>
<given-names>AJ</given-names></string-name>, editors. <source><italic toggle="yes">Hot Topics in Infection and Immunity in Children VIII</italic></source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2011</year>:<fpage>47</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Meyer Sauteur</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Unger</surname>
<given-names>WW</given-names></string-name>, <string-name><surname>Nadal</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Berger</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vink</surname>
<given-names>C</given-names></string-name>, <string-name><surname>van Rossum</surname>
<given-names>AM</given-names></string-name>. <article-title>Infection with and carriage of <italic>Mycoplasma pneumoniae</italic> in children</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2016</year>;<volume>7</volume>:<fpage>329</fpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-60327-353-4_8</pub-id><pub-id pub-id-type="pmid">27047456</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Diaz</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Winchell</surname>
<given-names>JM</given-names></string-name>. <article-title>The evolution of advanced molecular diagnostics for the detection and characterization of <italic>Mycoplasma pneumoniae</italic></article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2016</year>;<volume>7</volume>:<fpage>232</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.00232</pub-id><pub-id pub-id-type="pmid">27014191</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>She</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Thurber</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hymas</surname>
<given-names>WC</given-names></string-name>, et al. <article-title>Limited utility of culture for <italic>Mycoplasma pneumoniae</italic> and <italic>Chlamydophila pneumoniae</italic> for diagnosis of respiratory tract infections</article-title>. <source><italic toggle="yes">J Clin Microbiol</italic></source>. <year>2010</year>;<volume>48</volume>(<issue>9</issue>):<fpage>3380</fpage>&#x02013;<lpage>3382</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.00321-10</pub-id><pub-id pub-id-type="pmid">20610673</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Vervloet</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Marguet</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Camargos</surname>
<given-names>PA</given-names></string-name>. <article-title>Infection by <italic>Mycoplasma pneumoniae</italic> and its importance as an etiological agent in childhood community-acquired pneumonias</article-title>. <source><italic toggle="yes">Braz J Infect Dis</italic></source>. <year>2007</year>;<volume>11</volume>(<issue>5</issue>):<fpage>507</fpage>&#x02013;<lpage>514</lpage>.<pub-id pub-id-type="pmid">17962878</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Loens</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Goossens</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ieven</surname>
<given-names>M</given-names></string-name>. <article-title>Acute respiratory infection due to <italic>Mycoplasma pneumoniae</italic>: current status of diagnostic methods</article-title>. <source><italic toggle="yes">Eur J Clin Microbiol Infect Dis</italic></source>. <year>2010</year>;<volume>29</volume>(<issue>9</issue>):<fpage>1055</fpage>&#x02013;<lpage>1069</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10096-010-0975-2</pub-id><pub-id pub-id-type="pmid">20526788</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>PL</given-names></string-name>, et al. <article-title>Comparison of real-time polymerase chain reaction and serological tests for the confirmation of <italic>Mycoplasma pneumoniae</italic> infection in children with clinical diagnosis of atypical pneumonia</article-title>. <source><italic toggle="yes">J Microbiol Immunol Infect</italic></source>. <year>2014</year>;<volume>47</volume>(<issue>2</issue>):<fpage>137</fpage>&#x02013;<lpage>144</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmii.2013.03.015</pub-id><pub-id pub-id-type="pmid">23726653</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Medjo</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Atanaskovic-Markovic</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Radic</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nikolic</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lukac</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Djukic</surname>
<given-names>S</given-names></string-name>. <article-title><italic>Mycoplasma pneumoniae</italic> as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis</article-title>. <source><italic toggle="yes">Ital J Pediatr</italic></source>. <year>2014</year>;<volume>40</volume>:<fpage>104</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13052-014-0104-4</pub-id><pub-id pub-id-type="pmid">25518734</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Waites</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Balish</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>TP</given-names></string-name>. <article-title>New insights into the pathogenesis and detection of <italic>Mycoplasma pneumoniae</italic> infections</article-title>. <source><italic toggle="yes">Future Microbiol</italic></source>. <year>2008</year>;<volume>3</volume>(<issue>6</issue>):<fpage>635</fpage>&#x02013;<lpage>648</lpage>. doi:<pub-id pub-id-type="doi">10.2217/17460913.3.6.635</pub-id><pub-id pub-id-type="pmid">19072181</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Thurman</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Warner</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Cowart</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Benitez</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Winchell</surname>
<given-names>JM</given-names></string-name>. <article-title>Detection of <italic>Mycoplasma pneumoniae, Chlamydia pneumoniae</italic>, and <italic>Legionella</italic> spp. in clinical specimens using a single-tube multiplex real-time PCR assay</article-title>. <source><italic toggle="yes">Diagn Microbiol Infect Dis</italic></source>. <year>2011</year>;<volume>70</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2010.11.014</pub-id><pub-id pub-id-type="pmid">21397428</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>B</given-names></string-name>, <string-name><surname>He</surname>
<given-names>LH</given-names></string-name>, et al. <article-title>Evaluation of a new real-time PCR assay for detection of <italic>Mycoplasma pneumoniae</italic> in clinical specimens</article-title>. <source><italic toggle="yes">Biomed Environ Sci</italic></source>. <year>2012</year>;<volume>25</volume>(<issue>1</issue>):<fpage>77</fpage>&#x02013;<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.3967/0895-3988.2012.01.011</pub-id><pub-id pub-id-type="pmid">22424630</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Dumke</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jacobs</surname>
<given-names>E</given-names></string-name>. <article-title>Evaluation of five real-time PCR assays for detection of <italic>Mycoplasma pneumoniae</italic></article-title>. <source><italic toggle="yes">J Clin Microbiol</italic></source>. <year>2014</year>;<volume>52</volume>(<issue>11</issue>):<fpage>4078</fpage>&#x02013;<lpage>4081</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.02048-14</pub-id><pub-id pub-id-type="pmid">25210063</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Chaudhry</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Javed</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Passi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Dey</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>P</given-names></string-name>. <article-title>Molecular detection of <italic>Mycoplasma pneumoniae</italic> by quantitative real-time PCR in patients with community acquired pneumonia</article-title>. <source><italic toggle="yes">Indian J Med Res</italic></source>. <year>2013</year>;<volume>138</volume>:<fpage>244</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">24056602</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Nummi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mannonen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Puolakkainen</surname>
<given-names>M</given-names></string-name>. <article-title>Development of a multiplex real-time PCR assay for detection of <italic>Mycoplasma pneumoniae, Chlamydia pneumoniae</italic> and mutations associated with macrolide resistance in <italic>Mycoplasma pneumoniae</italic> from respiratory clinical specimens</article-title>. <source><italic toggle="yes">Springerplus</italic></source>. <year>2015</year>;<volume>4</volume>:<fpage>684</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40064-015-1457-x</pub-id><pub-id pub-id-type="pmid">26576327</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>D&#x000ed;az</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Ben&#x000ed;tez</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Cross</surname>
<given-names>KE</given-names></string-name>, et al. <article-title>Molecular detection and characterization of <italic>Mycoplasma pneumoniae</italic> among patients hospitalized with community-acquired pneumonia in the United States</article-title>. <source><italic toggle="yes">Open Forum Infect Dis</italic></source>. <year>2015</year>;<volume>2</volume>(<issue>3</issue>):<fpage>ofv106</fpage>. doi:<pub-id pub-id-type="doi">10.1093/ofid/ofv106</pub-id><pub-id pub-id-type="pmid">26284257</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Jain</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Arnold</surname>
<given-names>SR</given-names></string-name>, et al. <article-title>Community-acquired pneumonia requiring hospitalization among U.S. children</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2015</year>;<volume>372</volume>(<issue>9</issue>):<fpage>835</fpage>&#x02013;<lpage>845</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1405870</pub-id><pub-id pub-id-type="pmid">25714161</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Marchello</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dale</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Thai</surname>
<given-names>TN</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Ebell</surname>
<given-names>MH</given-names></string-name>. <article-title>Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: A meta-analysis</article-title>. <source><italic toggle="yes">Ann Fam Med</italic></source>. <year>2016</year>;<volume>14</volume>(<issue>6</issue>):<fpage>552</fpage>&#x02013;<lpage>566</lpage>. doi:<pub-id pub-id-type="doi">10.1370/afm.1993</pub-id><pub-id pub-id-type="pmid">28376442</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>B&#x000e9;net</surname>
<given-names>T</given-names></string-name>, <string-name><surname>S&#x000e1;nchez Picot</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Messaoudi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Microorganisms associated with pneumonia in children &#x0003c;5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case-control study</article-title>. <source><italic toggle="yes">Clin Infect Dis</italic></source>. <year>2017</year>;<volume>65</volume>(<issue>4</issue>):<fpage>604</fpage>&#x02013;<lpage>612</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/cix378</pub-id><pub-id pub-id-type="pmid">28605562</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>S&#x000e1;ez-Llorens</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Casta&#x000f1;o</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wubbel</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Importance of <italic>Mycoplasma pneumoniae</italic> and <italic>Chlamydia pneumoniae</italic> in children with community-acquired pneumonia</article-title>. <source><italic toggle="yes">Rev Med Panama</italic></source>. <year>1998</year>;<volume>23</volume>(<issue>2</issue>):<fpage>27</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">11214557</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Ferrero</surname>
<given-names>FC</given-names></string-name>, <string-name><surname>Osorio</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Eriksson</surname>
<given-names>PV</given-names></string-name>, <string-name><surname>Duran</surname>
<given-names>AP</given-names></string-name>. <article-title><italic>Mycoplasma pneumoniae</italic> en ni&#x000f1;os con neumon&#x000ed;a</article-title>. <source><italic toggle="yes">Arch Argent Pediatr</italic></source>. <year>2000</year>;<volume>98</volume>(<issue>1</issue>):<fpage>12</fpage>&#x02013;<lpage>17</lpage>.</mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Matute</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Brouwer</surname>
<given-names>WP</given-names></string-name>, <string-name><surname>Hak</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Delgado</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Alonso</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hoepelman</surname>
<given-names>IM</given-names></string-name>. <article-title>Aetiology and resistance patterns of community-acquired pneumonia in Le&#x000f3;n, Nicaragua</article-title>. <source><italic toggle="yes">Int J Antimicrob Agents</italic></source>. <year>2006</year>;<volume>28</volume>(<issue>5</issue>):<fpage>423</fpage>&#x02013;<lpage>427</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.07.016</pub-id><pub-id pub-id-type="pmid">17046211</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Herrera</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Aguilar</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Rueda</surname>
<given-names>ZV</given-names></string-name>, <string-name><surname>Muskus</surname>
<given-names>C</given-names></string-name>, <string-name><surname>V&#x000e9;lez</surname>
<given-names>LA</given-names></string-name>. <article-title>Comparison of serological methods with PCR-based methods for the diagnosis of community-acquired pneumonia caused by atypical bacteria</article-title>. <source><italic toggle="yes">J Negat Results Biomed</italic></source>. <year>2016</year>;<volume>15</volume>:<fpage>3</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12952-016-0047-y</pub-id><pub-id pub-id-type="pmid">26932735</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Del Valle-Mendoza</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Orellana-Peralta</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Marcelo-Rodr&#x000ed;guez</surname>
<given-names>A</given-names></string-name>, et al. <article-title>High prevalence of <italic>Mycoplasma pneumoniae</italic> and <italic>Chlamydia pneumoniae</italic> in children with acute respiratory infections from Lima, Peru</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e0170787</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0170787</pub-id><pub-id pub-id-type="pmid">28129377</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Jonnalagadda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Estrella</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sabin</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Semp&#x000e9;rtegui</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hamer</surname>
<given-names>DH</given-names></string-name>. <article-title>Etiology of severe pneumonia in Ecuadorian children</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>2</issue>):<fpage>e0171687</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0171687</pub-id><pub-id pub-id-type="pmid">28182741</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Gallego-Corella</surname>
<given-names>CI</given-names></string-name>, <string-name><surname>Trevi&#x000f1;o-Alvarado</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Rubio-P&#x000e9;rez</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Mart&#x000ed;nez-Longoria</surname>
<given-names>C</given-names></string-name>, <string-name><surname>De la O-Cavazos</surname>
<given-names>M</given-names></string-name>. <article-title>Presentaci&#x000f3;n cl&#x000ed;nico-radiol&#x000f3;gica de la infecci&#x000f3;n por <italic>Mycoplasma pneumoniae</italic> en pediatr&#x000ed;a</article-title>. <source><italic toggle="yes">Med Univ</italic></source>. <year>2011</year>;<volume>13</volume>(<issue>53</issue>):<fpage>200</fpage>&#x02013;<lpage>206</lpage>.</mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Rodr&#x000ed;guez de Ita</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Torres-Quintanilla</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pal&#x000e1;u-D&#x000e1;vila</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Clinical score to rule out pneumonia due to <italic>Mycoplasma pneumoniae</italic></article-title>. <source><italic toggle="yes">An Pediatr (Barc)</italic></source>. <year>2014</year>;<volume>81</volume>(<issue>4</issue>):<fpage>241</fpage>&#x02013;<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anpedi.2013.11.024</pub-id><pub-id pub-id-type="pmid">24534005</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Romero-Espinoza</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Moreno-Valencia</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Coronel-Tellez</surname>
<given-names>RH</given-names></string-name>, et al. <article-title>Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2018</year>;<volume>13</volume>(<issue>2</issue>):<fpage>e0192878</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0192878</pub-id><pub-id pub-id-type="pmid">29447223</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="book"><string-name><surname>Ahsan</surname>
<given-names>S</given-names></string-name>,&#x000a0;<string-name><surname>Noether</surname>
<given-names>NJ</given-names></string-name>. Hematolog&#x000ed;a. In: <string-name><surname>Robertson</surname>
<given-names>J</given-names></string-name>, <collab>Johns Hopkins Hospital</collab>, editors. <source><italic toggle="yes">Manual Harriet Lane De Pediatr&#x000ed;a: Para La Asistencia Pedi&#x000e1;trica Ambulatoria</italic></source>. <publisher-loc>Espa&#x000f1;a</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>2006</year>:322&#x02013;353.</mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Ling</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>McHugh</surname>
<given-names>TD</given-names></string-name>. <article-title>Rapid detection of atypical respiratory bacterial pathogens by real-time PCR</article-title>. <source><italic toggle="yes">Methods Mol Biol</italic></source>. <year>2013</year>;<volume>943</volume>:<fpage>125</fpage>&#x02013;<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-60327-353-4_8</pub-id><pub-id pub-id-type="pmid">23104286</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Tatti</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Sparks</surname>
<given-names>KN</given-names></string-name>, <string-name><surname>Boney</surname>
<given-names>KO</given-names></string-name>, <string-name><surname>Tondella</surname>
<given-names>ML</given-names></string-name>. <article-title>Novel multitarget real-time PCR assay for rapid detection of <italic>Bordetella</italic> species in clinical specimens</article-title>. <source><italic toggle="yes">J Clin Microbiol</italic></source>. <year>2011</year>;<volume>49</volume>(<issue>12</issue>):<fpage>4059</fpage>&#x02013;<lpage>4066</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.00601-11</pub-id><pub-id pub-id-type="pmid">21940464</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Morgulis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Coulouris</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Raytselis</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Madden</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Agarwala</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sch&#x000e4;ffer</surname>
<given-names>AA</given-names></string-name>. <article-title>database indexing for production. Database indexing for production MegaBLAST searches</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>. <year>2008</year>;<volume>24</volume>(<issue>16</issue>):<fpage>1757</fpage>&#x02013;<lpage>1764</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btn322</pub-id><pub-id pub-id-type="pmid">18567917</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wagner</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>W</given-names></string-name>. <article-title>A greedy algorithm for aligning DNA sequences</article-title>. <source><italic toggle="yes">J Comput Biol</italic></source>. <year>2000</year>;<volume>7</volume>(<issue>1&#x02013;2</issue>):<fpage>203</fpage>&#x02013;<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1089/10665270050081478</pub-id><pub-id pub-id-type="pmid">10890397</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Ma</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>YH</given-names></string-name>, et al. <article-title>Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance</article-title>. <source><italic toggle="yes">J Microbiol Immunol Infect</italic></source>. <year>2015</year>;<volume>48</volume>(<issue>6</issue>):<fpage>632</fpage>&#x02013;<lpage>638</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmii.2014.08.003</pub-id><pub-id pub-id-type="pmid">25311405</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Huong Ple</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hien</surname>
<given-names>PT</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Binh</surname>
<given-names>TQ</given-names></string-name>, <string-name><surname>Tuan</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Anh</surname>
<given-names>DD</given-names></string-name>. <article-title>First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1&#x02013;15 years</article-title>. <source><italic toggle="yes">BMC Public Health</italic></source>. <year>2014</year>;<volume>14</volume>:<fpage>1304</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2458-14-1304</pub-id><pub-id pub-id-type="pmid">25524126</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Gao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yue</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Xiao</surname>
<given-names>M</given-names></string-name>. <article-title>Epidemiology and clinical features of segmental/lobar pattern <italic>Mycoplasma pneumoniae</italic> pneumonia: A ten-year retrospective clinical study</article-title>. <source><italic toggle="yes">Exp Ther Med</italic></source>. <year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>2337</fpage>&#x02013;<lpage>2344</lpage>. doi:<pub-id pub-id-type="doi">10.3892/etm.2015.2818</pub-id><pub-id pub-id-type="pmid">26668638</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Lassmann</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Poetschke</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ninteretse</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Community-acquired pneumonia in children in Lambarene, Gabon</article-title>. <source><italic toggle="yes">Am J Trop Med Hyg</italic></source>. <year>2008</year>;<volume>79</volume>(<issue>1</issue>):<fpage>109</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">18606773</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Kurz</surname>
<given-names>H</given-names></string-name>, <string-name><surname>G&#x000f6;pfrich</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Huber</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Spectrum of pathogens of in-patient children and youths with community acquired pneumonia: a 3 year survey of a community hospital in Vienna, Austria</article-title>. <source><italic toggle="yes">Wien Klin Wochenschr</italic></source>. <year>2013</year>;<volume>125</volume>(<issue>21&#x02013;22</issue>):<fpage>674</fpage>&#x02013;<lpage>679</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00508-013-0459-3</pub-id><pub-id pub-id-type="pmid">24081607</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Cantais</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mory</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Pillet</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Epidemiology and microbiological investigations of community-acquired pneumonia in children admitted at the emergency department of a university hospital</article-title>. <source><italic toggle="yes">J Clin Virol</italic></source>. <year>2014</year>;<volume>60</volume>(<issue>4</issue>):<fpage>402</fpage>&#x02013;<lpage>407</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jcv.2014.05.006</pub-id><pub-id pub-id-type="pmid">24915939</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Mathew</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Singhi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ray</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Etiology of community acquired pneumonia among children in India: prospective, cohort study</article-title>. <source><italic toggle="yes">J Glob Health</italic></source>. <year>2015</year>;<volume>5</volume>(<issue>2</issue>):<fpage>050418</fpage>. doi:<pub-id pub-id-type="doi">10.7189/jogh.05.020418</pub-id><pub-id pub-id-type="pmid">26528392</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Diaz</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Desai</surname>
<given-names>HP</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>SS</given-names></string-name>, et al. <article-title>Correction: comprehensive bioinformatics analysis of <italic>Mycoplasma pneumoniae</italic> genomes to investigate underlying population structure and type-specific determinants</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>10</issue>):<fpage>e0186030</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0186030</pub-id><pub-id pub-id-type="pmid">28977025</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Kicinski</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Wisniewska-Ligier</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wozniakowska-Gesicka</surname>
<given-names>T</given-names></string-name>. <article-title>Pneumonia caused by <italic>Mycoplasma pneumoniae</italic> and <italic>Chlamydophila pneumoniae</italic> in children - comparative analysis of clinical picture</article-title>. <source><italic toggle="yes">Adv Med Sci</italic></source>. <year>2011</year>;<volume>56</volume>(<issue>1</issue>):<fpage>56</fpage>&#x02013;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.2478/v10039-011-0017-z</pub-id><pub-id pub-id-type="pmid">21515486</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Youn</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Rhim</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>KY</given-names></string-name>. <article-title>Epidemiological comparison of three <italic>Mycoplasma pneumoniae</italic> pneumonia epidemics in a single hospital over 10 years</article-title>. <source><italic toggle="yes">Korean J Pediatr</italic></source>. <year>2015</year>;<volume>58</volume>(<issue>5</issue>):<fpage>172</fpage>&#x02013;<lpage>177</lpage>. doi:<pub-id pub-id-type="doi">10.3345/kjp.2015.58.5.172</pub-id><pub-id pub-id-type="pmid">26124847</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Tian</surname>
<given-names>DD</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>Q</given-names></string-name>. <article-title>Meteorological factors on the incidence of MP and RSV pneumonia in children</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>3</issue>):<fpage>e0173409</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0173409</pub-id><pub-id pub-id-type="pmid">28282391</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Oumei</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xuefeng</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Jianping</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Etiology of community-acquired pneumonia in 1500 hospitalized children</article-title>. <source><italic toggle="yes">J Med Virol</italic></source>. <year>2018</year>;<volume>90</volume>(<issue>30</issue>):<fpage>421</fpage>&#x02013;<lpage>428</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jmv.24963</pub-id><pub-id pub-id-type="pmid">28975629</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Chiu</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Chiu</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>YC</given-names></string-name>. <article-title>Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia</article-title>. <source><italic toggle="yes">J Microbiol Immunol Infect</italic></source>. <year>2015</year>;<volume>48</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>56</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmii.2013.06.006</pub-id><pub-id pub-id-type="pmid">23927825</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Nadagir</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Kaleem Bahadur</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Anantappa Shepur</surname>
<given-names>T</given-names></string-name>. <article-title>Prevalence of <italic>Mycoplasma pneumoniae</italic> among HIV infected children</article-title>. <source><italic toggle="yes">Indian J Pediatr</italic></source>. <year>2011</year>;<volume>78</volume>(<issue>4</issue>):<fpage>430</fpage>&#x02013;<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12098-010-0313-9</pub-id><pub-id pub-id-type="pmid">21161445</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Cabral-Marques</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Klaver</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schimke</surname>
<given-names>LF</given-names></string-name>, et al. <article-title>First report of the hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes</article-title>. <source><italic toggle="yes">J Clin Immunol</italic></source>. <year>2014</year>;<volume>34</volume>(<issue>2</issue>):<fpage>146</fpage>&#x02013;<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10875-013-9980-4</pub-id><pub-id pub-id-type="pmid">24402618</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>B&#x000e9;b&#x000e9;ar</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Raherison</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Nacka</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Comparison of <italic>Mycoplasma pneumoniae</italic> infections in asthmatic children versus asthmatic adults</article-title>. <source><italic toggle="yes">Pediatr Infect Dis J</italic></source>. <year>2014</year>;<volume>33</volume>(<issue>3</issue>):<fpage>e71</fpage>&#x02013;<lpage>75</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0000000000000309</pub-id><pub-id pub-id-type="pmid">24030350</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Iramain</surname>
<given-names>R</given-names></string-name>, <string-name><surname>De Jes&#x000fa;s</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Spitters</surname>
<given-names>C</given-names></string-name>, et al. <article-title><italic>Chlamydia pneumoniae</italic>, and <italic>Mycoplasma pneumoniae</italic>: are they related to severe asthma in childhood?</article-title>
<source><italic toggle="yes">J Asthma</italic></source>. <year>2016</year>;<volume>53</volume>(<issue>6</issue>):<fpage>618</fpage>&#x02013;<lpage>621</lpage>. doi:<pub-id pub-id-type="doi">10.3109/02770903.2015.1116085</pub-id><pub-id pub-id-type="pmid">27120360</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Inchley</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Berg</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Vahdani Benam</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kvissel</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Leegaard</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Nakstad</surname>
<given-names>B</given-names></string-name>. <article-title><italic>Mycoplasma pneumoniae</italic>: a cross-sectional population-based comparison of disease severity in preschool and school-age children</article-title>. <source><italic toggle="yes">Pediatr Infect Dis J</italic></source>. <year>2017</year>;<volume>36</volume>(<issue>10</issue>):<fpage>930</fpage>&#x02013;<lpage>936</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0000000000001628</pub-id><pub-id pub-id-type="pmid">28471864</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Copete</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Aguilar</surname>
<given-names>YA</given-names></string-name>, <string-name><surname>Rueda</surname>
<given-names>ZV</given-names></string-name>, <string-name><surname>V&#x000e9;lez</surname>
<given-names>LA</given-names></string-name>. <article-title>Genotyping and macrolide resistance of <italic>Mycoplasma pneumoniae</italic> identified in children with community-acquired pneumonia in Medell&#x000ed;n, Colombia</article-title>. <source><italic toggle="yes">Int J Infect Dis</italic></source>. <year>2018</year>;<volume>66</volume>:<fpage>113</fpage>&#x02013;<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijid.2017.11.019</pub-id><pub-id pub-id-type="pmid">29155089</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Han</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HJ</given-names></string-name>, et al. <article-title>Contribution of co-detected respiratory viruses and patient age to the clinical manifestations of <italic>Mycoplasma pneumoniae</italic> pneumonia in children</article-title>. <source><italic toggle="yes">Pediatr Infect Dis J</italic></source>. <year>2018</year>;<volume>37</volume>(<issue>6</issue>):<fpage>531</fpage>&#x02013;<lpage>536</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0000000000001819</pub-id><pub-id pub-id-type="pmid">29095244</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Ravelomanana</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bouazza</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rakotomahefa</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Prevalence of <italic>Mycoplasma pneumoniae</italic> infection in Malagasy children</article-title>. <source><italic toggle="yes">Pediatr Infect Dis J</italic></source>. <year>2017</year>;<volume>36</volume>(<issue>5</issue>):<fpage>467</fpage>&#x02013;<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1097/INF.0000000000001471</pub-id><pub-id pub-id-type="pmid">28403048</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Guo</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Hao</surname>
<given-names>CL</given-names></string-name>. <article-title>Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study</article-title>. <source><italic toggle="yes">BMJ Open</italic></source>. <year>2015</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e006766</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2014-006766</pub-id></mixed-citation></ref><ref id="CIT0056"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Youn</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>KY</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>JY</given-names></string-name>, et al. <article-title>Difference of clinical features in childhood <italic>Mycoplasma pneumoniae</italic> pneumonia</article-title>. <source><italic toggle="yes">BMC Pediatr</italic></source>. <year>2010</year>;<volume>10</volume>:<fpage>48</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2431-10-48</pub-id><pub-id pub-id-type="pmid">20604923</pub-id></mixed-citation></ref><ref id="CIT0057"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>W</given-names></string-name>, et al. <article-title>Evaluation of variation in coagulation among children with <italic>Mycoplasma pneumoniae</italic> pneumonia: a case-control study</article-title>. <source><italic toggle="yes">J Int Med Res</italic></source>. <year>2017</year>;<volume>45</volume>(<issue>6</issue>):<fpage>2110</fpage>&#x02013;<lpage>2118</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0300060517709613</pub-id><pub-id pub-id-type="pmid">28643533</pub-id></mixed-citation></ref><ref id="CIT0058"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>HQ</given-names></string-name>, et al. <article-title>Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of <italic>Mycoplasma pneumoniae</italic> infection in children with pneumonia</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e0177842</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0177842</pub-id><pub-id pub-id-type="pmid">28520818</pub-id></mixed-citation></ref><ref id="CIT0059"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Saraya</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tsukahara</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>The correlation between chest X-ray scores and the clinical findings in children and adults with <italic>Mycoplasma pneumoniae</italic> pneumonia</article-title>. <source><italic toggle="yes">Intern Med</italic></source>. <year>2017</year>;<volume>56</volume>(<issue>21</issue>):<fpage>2845</fpage>&#x02013;<lpage>2849</lpage>. doi:<pub-id pub-id-type="doi">10.2169/internalmedicine.8500-16</pub-id><pub-id pub-id-type="pmid">28943541</pub-id></mixed-citation></ref><ref id="CIT0060"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Kutty</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>Jain</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>TH</given-names></string-name>, et al. <article-title><italic>Mycoplasma pneumoniae</italic> among children hospitalized with community-acquired pneumonia</article-title>. <source><italic toggle="yes">Clin Infect Dis</italic></source>. <year>2019</year>;<volume>68</volume>(<issue>1</issue>):<fpage>5</fpage>&#x02013;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciy419</pub-id><pub-id pub-id-type="pmid">29788037</pub-id></mixed-citation></ref><ref id="CIT0061"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Khoury</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sviri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rmeileh</surname>
<given-names>AA</given-names></string-name>, et al. <article-title>Increased rates of intensive care unit admission in patients with <italic>Mycoplasma pneumoniae</italic>: a retrospective study</article-title>. <source><italic toggle="yes">Clin Microbiol Infect</italic></source>. <year>2016</year>;<volume>22</volume>(<issue>8</issue>):<fpage>711</fpage>&#x02013;<lpage>714</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2016.05.028</pub-id><pub-id pub-id-type="pmid">27297319</pub-id></mixed-citation></ref><ref id="CIT0062"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Mu</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Sung</surname>
<given-names>TC</given-names></string-name>. <article-title>Fatal community-acquired pneumonia: 18 years in a medical center</article-title>. <source><italic toggle="yes">Pediatr Neonatol</italic></source>. <year>2013</year>;<volume>54</volume>(<issue>1</issue>):<fpage>22</fpage>&#x02013;<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pedneo.2012.11.003</pub-id><pub-id pub-id-type="pmid">23445739</pub-id></mixed-citation></ref><ref id="CIT0063"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Kannan</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Hardy</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Coalson</surname>
<given-names>JJ</given-names></string-name>, et al. <article-title>Fatal outcomes in family transmission of <italic>Mycoplasma pneumoniae</italic></article-title>. <source><italic toggle="yes">Clin Infect Dis</italic></source>. <year>2012</year>;<volume>54</volume>(<issue>2</issue>):<fpage>225</fpage>&#x02013;<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/cir769</pub-id><pub-id pub-id-type="pmid">22052890</pub-id></mixed-citation></ref><ref id="CIT0064"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Waites</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Talkington</surname>
<given-names>DF</given-names></string-name>. <article-title><italic>Mycoplasma pneumoniae</italic> and its role as a human pathogen</article-title>. <source><italic toggle="yes">Clin Microbiol Rev</italic></source>. <year>2004</year>;<volume>17</volume>(<issue>4</issue>):<fpage>697</fpage>&#x02013;<lpage>728</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.17.4.697-728.2004</pub-id><pub-id pub-id-type="pmid">15489344</pub-id></mixed-citation></ref></ref-list></back></article>